Gastric Stasis


Article Author:
Avanija Buddam


Article Editor:
Sunil Dacha


Editors In Chief:
Chaddie Doerr


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Frank Smeeks
Kristina Soman-Faulkner
Radia Jamil
Patrick Le
Sobhan Daneshfar
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
5/2/2019 11:36:19 PM

Introduction

Gastroparesis (gastric stasis) is derived from Greek words gastro/gaster or stomach, and paresis or partial paralysis. It is a clinical condition resulting from delayed gastric emptying in the absence of mechanical obstruction and is associated with upper gastrointestinal symptoms. Most common symptoms include nausea, vomiting, early satiety, postprandial fullness, upper abdominal pain, bloating, and weight loss. These symptoms can be severely disabling and can adversely impact the quality of life in patients suffering from this disorder. Several etiologies can lead to this clinical entity; the most common of these are idiopathic, diabetic and postsurgical. Pathophysiology of gastroparesis is poorly understood, but important mechanisms associated are the loss of interstitial cells of Cajal and inability to express neuronal nitric oxide synthase. Gastric emptying scintigraphy (gold standard), 13C-octanoate breath testing, and a wireless motility capsule are the diagnostic tests used to diagnose this condition. Management of gastroparesis includes initial restoration of the nutritional state, optimizing glycemic control, symptom relief and improvement in gastric emptying. Medical management includes the use of prokinetic agents such as metoclopramide, erythromycin, and anti-emetic agents. Endoscopic and surgical methods are used for refractory cases. Intrapyloric botulinum injection, gastric electrical stimulation, venting gastrostomy, feeding jejunostomy, pyloroplasty, partial gastrectomy and most recently endoscopic techniques such gastric peroral endoscopic myotomy (G-POEM) are being utilized for relieving symptoms.[1][2][3]

Etiology

The most common etiologies for gastroparesis are Idiopathic in 64%, diabetes in 31%, and post-surgical in the remaining patients. Other less frequent etiologies include association with functional bowel disorders, dysmotility syndromes, Chagas disease, post-viral, neurological disorders, endocrine conditions, connective tissue disorders, radiation,  gastric ischemia, and medications (opioids, anticholinergics, anti-diabetic medications).[4]

Epidemiology

Estimating the prevalence of gastroparesis is a great challenge as symptoms usually are not comparable to a gastric emptying study. According to an epidemiologic study from Olmsted County, the prevalence of gastroparesis was found to be 24.2 per 100,000 persons and incidence of 6.3 per 100,000 persons per year.

Pathophysiology

The pathophysiology of gastroparesis is poorly understood and is not well defined, but important mechanisms associated are the loss of interstitial cells of Cajal and inability to express neuronal nitric oxide synthase. For gastric emptying to occur there needs interaction between smooth muscles, extrinsic nerves, intrinsic or enteric nerves and interstitial cells of Cajal (ICC). It has been hypothesized that there might be a poor interplay between local enteric system along with decreased local secretion of nitric oxide(NO). Nitric oxide is required for smooth muscle relaxation, as a result causing accommodation of fundus and impairment in pyloric muscle relaxation. ICC generate slow wave and transmit to the smooth muscle thus enabling contraction, which is impaired with loss of ICC. Thus both contributing to delayed gastric emptying. There are several ongoing studies to determine pathophysiology, expect to improve our understanding soon.[5][6][7]

Histopathology

Histopathologic studies from tissues of diabetic and idiopathic gastroparesis patients showed several changes like loss of ICC, decreased nerve fibers, increased smooth muscle fibrosis, and abnormal macrophage-containing immune infiltrates. On electron microscopy, there is abnormal connective tissue stroma, thick basal lamina around ICCs and myocytes, and large empty nerve endings suggest more profound conduction defects, which supports the above discussion.

History and Physical

Patients present commonly with cardinal symptoms like nausea, vomiting, early satiety, postprandial fullness, upper abdominal pain, bloating and weight loss. The gastroparesis cardinal symptom index (GCSI) is a validated clinical instrument that be can be used to assess symptoms in patients suffering from gastroparesis. This instrument has three subscales: (fullness/early satiety, nausea/vomiting, and bloating) and rates of symptom intensities from zero (none) to five (very severe) and the total is used for severity of the disease. The GCSI is used to assess response to therapy and not primarily as a diagnostic tool. In addition to gastric symptoms, the slow and unpredictable gastric emptying can cause wide fluctuations in blood sugar levels especially so in diabetic patients. In addition, this may cause weight loss, fatigue, calorie deficit, gastric bezoar formation.

Evaluation

Initial assessment of upper gastrointestinal tract by esophagogastroduodenoscopy or barium radiography is done to rule out a mechanical obstruction. The most common test used in clinical practice is the gastric scintigraphic emptying of solids. A study result of retention of solids at 4 hours is considered to be diagnostic of gastroparesis. Other alternative methods to assess gastric emptying include motility testing by a wireless capsule and 13 C breath testing using octanoate or spirulina integrated into a solid meal. Drugs that affect the gastric emptying should be held at least 48 hours prior to the study. Furthermore, patients with diabetes should have plasma blood glucose less than 275 mg/dl to eliminate acute impairment of gastric emptying from hyperglycemia.[8][9][10][11]

Treatment / Management

Diet and Lifestyle Changes

The initial goal of management of gastroparesis is the restoration of fluid and electrolyte balance. Also, nutritional status and blood sugar levels should be optimized. Dietary modifications include switching to small frequent meals, low-fat diet. Drinks such as carbonated and alcoholic beverages and foods rich in insoluble fiber should be avoided entirely. In addition, quitting smoking has also been reported to be helpful. Oral intake is encouraged, and if the patient does not tolerate solid foods, then liquid diet could be attempted. In case of intolerance to oral diet, enteral feeding by post-pyloric feeding tube can be used. Parenteral nutrition is not encouraged and remains the last alternative if everything else fails.[12][13][14]

Pharmacological  and Surgical Methods

Use of prokinetics like metoclopramide, erythromycin and anti-emetics can help relieve symptoms. Metoclopramide is the first-line agent; it is a dopamine D2 receptor antagonist that increases contractility, resting tone of GI tract and thereby promotes gastric emptying. It is recommended to use the lowest possible dose for the shortest duration of time given its extrapyramidal side effects unless benefits outweigh risks. Domperidone is similar to metoclopramide but with fewer central side effects and can be used when there are adverse effects with the use of metoclopramide. It is not FDA approved for use in the USA.  Domperidone can be prescribed by obtaining expanded access investigational new drug from FDA. Erythromycin can be used for a short course to promote gastric emptying, but prolonged use is associated with tachyphylaxis and should be used sparingly. Other antiemetics used are prochlorperazine, promethazine, ondansetron, and tricyclic agents such as nortriptyline in the case of refractory emesis.

Intrapyloric botulinum injections have been demonstrated to improve symptoms in patients that are refractory to above medical therapies. The effects of the botulinum injections last for about 3 to 6 months. Lack of randomized controlled trials to support the use of botulinum is the main limitation. A gastric electrical stimulator (GES) used in refractory patients as an alternative modality, it delivers high frequency and low energy stimulation to the stomach, thus enhancing gastric motility. Studies have also shown improvement in symptoms and gastric emptying from the use of GES. Surgical approaches include venting gastrostomy, feeding jejunostomy, pyloroplasty and partial gastrectomy are performed when medical therapy fails for symptom relief. A new emerging, less invasive endoscopic technique gastric peroral endoscopic myotomy (G-POEM) is being evaluated to the relieve the symptoms of gastroparesis. The initial studies are encouraging, will need further studies to evaluate efficacy and safety.

Differential Diagnosis

Gastroparesis mimics several other conditions such as like anorexia nervosa, bulimia, and rumination syndrome. Therefore, these conditions need to be excluded prior to making a diagnosis of gastroparesis. Other conditions such as cyclical vomiting syndrome and chronic cannabinoid use may also have a similar clinical pattern as gastroparesis.

Pearls and Other Issues

Gastroparesis is a clinical condition associated with obstructive gastric symptoms in the absence of mechanical obstruction that is observed in a variety of clinical conditions. There is no definitive treatment for this condition currently. Unfortunately, management options are limited and mostly focused on symptom relief. Several new treatment alternatives are emerging to manage this condition but need further studies to evaluate clinical benefit.

Enhancing Healthcare Team Outcomes

Gastric stasis is associated with high morbidity and because of the many causes, the condition is best managed by a multidisciplinary team that includes a gastroenterologist, endocrinologist, surgeon, internist, pharmacist, dietitian and the primary care provider. The pharmacist has to ensure that the patient is not on any medications that cause gastric paralysis. All reversible causes have to be sought and treated. Diabetics need to manage their blood sugars well. Unfortunately, despite optimal treatment, gastric stasis is often a chronic problem that leads to poor quality of life. Some patients need continuous TPN and others need comprehensive changes in diet and lifestyle.

To date, the use of prokinetic drugs has not been effective. Placement of pacemakers in the stomach does work in a few people but there are no long term studies.

 

Surgical approaches include venting gastrostomy, feeding jejunostomy, pyloroplasty and partial gastrectomy are performed when medical therapy fails for symptom relief. [15][16]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Gastric Stasis - Questions

Take a quiz of the questions on this article.

Take Quiz
A 54-year-old female patient with a history of poorly controlled diabetes mellitus type 2, hypertension, and obesity presents with complaints of bloating, postprandial fullness, nausea, and vomiting for several days. She denies any recent illness, travel, or use of new medications. On physical examination, vitals are within normal limits, abdominal exam shows slight distention, and no tenderness elicited. Labs show hemoglobin A1c 9%, blood glucose 260 mg/dL, and potassium 3.5 mEq/L. What is next best step in evaluating this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 57-year-old female patient with a history of poorly controlled diabetes mellitus type 2, hypertension, and obesity presents with complaints of bloating, postprandial fullness, nausea, and vomiting for several days. She had a recent esophagogastroduodenoscopy with no acute abnormalities and was diagnosed with gastroparesis based on a gastric emptying study. What is the next best step in management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 59-year-old female with a diagnosis of idiopathic gastroparesis was started on metoclopramide a few months ago as prior interventions, such as dietary modification, were not helpful. She reports improved nausea, vomiting, and bloating symptoms. She notices increased lip tremors and leg restlessness, which are progressively getting worse. What is the next step in management?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Erythromycin is one of the prokinetic medications that can be used in the treatment of gastroparesis. Why is it not useful for long-term treatment?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 50-year-old female patient with long-standing diabetes mellitus is suspected to have gastroparesis based on symptoms. What is the gold standard test aiding in the diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
In patients with a diagnosis of gastric stasis, what are the recommended dietary changes that have shown improvement in symptoms?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Gastric Stasis - References

References

Zhang H,Zhang J,Jiang A,Ni H, Gastric peroral endoscopic myotomy for gastroparesis: A systematic review of efficacy and safety. Gastroenterologia y hepatologia. 2019 Apr 3;     [PubMed]
Miller AC,Khan AM,Castro Bigalli AA,Sewell KA,King AR,Ghadermarzi S,Mao Y,Zehtabchi S, Neuroleptanalgesia for acute abdominal pain: a systematic review. Journal of pain research. 2019;     [PubMed]
Fehnel S,Fiedorek FT,Nelson L,DiBenedetti D,Spence S,Carson RT, Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary. Clinical and experimental gastroenterology. 2019;     [PubMed]
Moshiree B,Potter M,Talley NJ, Epidemiology and Pathophysiology of Gastroparesis. Gastrointestinal endoscopy clinics of North America. 2019 Jan;     [PubMed]
Vijayvargiya P,Camilleri M,Chedid V,Mandawat A,Erwin PJ,Murad MH, Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis. Gastroenterology. 2019 May;     [PubMed]
Bekkelund M,Sangnes DA,Gunnar Hatlebakk J,Aabakken L, Pathophysiology of idiopathic gastroparesis and implications for therapy. Scandinavian journal of gastroenterology. 2019 Jan;     [PubMed]
Kim BJ,Kuo B, Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment. Journal of neurogastroenterology and motility. 2019 Jan 31;     [PubMed]
Burlen J,Runnels M,Mehta M,Andersson S,Ducrotte P,Gourcerol G,Lindberg G,Fullarton G,Abrahamsson H,Al-Juburi A,Lahr C,Rashed H,Abell T, Efficacy of Gastric Electrical Stimulation for Gastroparesis: US/European Comparison. Gastroenterology research. 2018 Oct;     [PubMed]
Tack J,Van den Houte K,Carbone F, Gastroduodenal motility disorders. Current opinion in gastroenterology. 2018 Nov;     [PubMed]
Haskins SC,Kruisselbrink R,Boublik J,Wu CL,Perlas A, Gastric Ultrasound for the Regional Anesthesiologist and Pain Specialist. Regional anesthesia and pain medicine. 2018 Oct;     [PubMed]
Krishnasamy S,Abell TL, Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2018 Jul;     [PubMed]
Santhanam P,Marashdeh W,Solnes L, Functional Imaging of Evaluation of Diabetic Gastroparesis. Current diabetes reviews. 2018;     [PubMed]
Tillman EM,Smetana KS,Bantu L,Buckley MG, Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016 Mar-Apr;     [PubMed]
Schulze T,Heidecke CD, [Treatment of postoperative impairment of gastrointestinal motility, cholangitis and pancreatitis]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2015 Jun;     [PubMed]
Arnold G,Beaves M, Update on clinical guidelines for the management of gastroparesis. The American journal of gastroenterology. 2013 Sep;     [PubMed]
Vanormelingen C,Tack J,Andrews CN, Diabetic gastroparesis. British medical bulletin. 2013;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of CNS-Diabetes Management. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for CNS-Diabetes Management, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in CNS-Diabetes Management, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of CNS-Diabetes Management. When it is time for the CNS-Diabetes Management board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study CNS-Diabetes Management.